Stay updated on Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.

Latest updates to the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page
- Check3 days agoChange DetectedAdded revision note indicating the current page version (v3.5.0) and removed the previous v3.4.3. This update reflects backend versioning rather than substantive changes to the study details.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page. This appears to be a versioning update rather than substantive content changes.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe update adds Revision: v3.4.2 and removes Revision: v3.4.1, which appears to be a minor version label change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedVersion numbers updated from v3.4.0 to v3.4.1; no user-facing changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded a glossary toggle, updated QC-related labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and updated the revision tag to v3.4.0.SummaryDifference0.2%

- Check68 days agoChange DetectedRevision: v3.3.4 is now displayed instead of v3.3.3. This is a minor site version update and does not alter any study details or user-facing content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.